| bibliographicCitation |
Rauck, MD RL, Bookbinder, MD SA, Bunker, MD TR, Alftine, MD CD, Ghalie, MD R, Negro-Vilar, MD, PhD A, De Jong, MD E, Gershon, MD S. A randomized, open-label study of once-a-day AVINZA® (morphine sulfate extended-release capsules) versus twice-a-day OxyContin® (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: The extension phase of the ACTION trial. J of Opioid Management. 2006 Nov 01;2(6):325–33. doi: 10.5055/jom.2006.0048. |